American Health Line rounds up the latest health care news in the states.

The Trump administration on Wednesday announced that FDA intends to finalize a compliance policy that will clear the market of unauthorized, non-tobacco-flavored e-cigarettes, including mint and menthol flavors, in response to growing numbers of children using e-cigarettes.

Purdue Pharma, the maker of OxyContin, and its owners, the Sackler family, have reached a tentative settlement with nearly two dozen states and thousands of U.S. cities, counties, and territories suing the company for allegedly contributing to the U.S. opioid epidemic.

The Federal Trade Commission on Tuesday announced that it has warned three companies for advertising that their cannabidiol products can treat medical conditions without evidence to support those claims.

FDA on Monday announced that it has warned e-cigarette maker Juul Labs for illegally marketing its nicotine pods as a less harmful alternative to traditional cigarettes, and for doing so in a presentation to youth at a U.S. school.

Drugmaker Mallinckrodt Pharmaceuticals on Friday announced that it has reached a "settlement in principle" with two Ohio counties in a lawsuit scheduled to go to trial next month that claims opioid drugmakers, distributors, and others contributed to the U.S. opioid epidemic.

Public health officials on Friday reported more deaths likely caused by a lung illness tied to e-cigarette use and vaping, as federal health agencies issued conflicting warnings about vaping and e-cigarette use.

While medication-assisted treatment is considered "the gold standard" for managing opioid-related substance use disorders, most state programs for health care professionals seeking to recover from opioid use disorders often deny access to such medications.

Federal and state health officials this week announced they have identified high levels of vitamin E acetate in samples of marijuana vaping products that have been linked to a deadly lung illness affecting patients across the United States.

Sean Blake died of a drug-related overdose in August 2017, after nearly a decade cycling in and out of substance use disorder (SUD) treatment programs that cost his family $110,000—a story that highlights the flaws in the U.S. SUD treatment system.